Regent Logo

Mergers and Acquistions News

Categories: IT Services & Consulting, Software

June 9th 2010, 18:05PM

The merger of Allscripts, a US healthcare software firm with rival Eclipsys, has been announced today (June 9th).

Allscripts said it will buy Eclipsys in an all-share deal worth $1.3 billion (£900 million), offering Eclipsys investors 1.2 Allscript shares for each of their shares.

Glen Tullman, the chief executive officer of Allscripts, will head up the new combined company.

He said: "We are at the beginning of what we believe will be the single fastest transformation of any industry in US history.

"Our vision ... is to leverage information technology to create collaboration between providers in all care settings, helping to improve the quality and lower the cost of care."

The new company is in an ideal position to exploit the trend towards electronic records, he added.

Meanwhile Misys, a British software company, said it would cut its 55 percent stake in Allscripts to around 10 percent, returning more than $1 billion (£690 million) to investors, according to Reuters.

ADNFCR-1833-ID-19828460-ADNFCR

 

Related News